1. Home
  2. LIXT vs VNCE Comparison

LIXT vs VNCE Comparison

Compare LIXT & VNCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lixte Biotechnology Holdings Inc.

LIXT

Lixte Biotechnology Holdings Inc.

HOLD

Current Price

$7.00

Market Cap

26.5M

Sector

Health Care

ML Signal

HOLD

Logo Vince Holding Corp.

VNCE

Vince Holding Corp.

HOLD

Current Price

$4.39

Market Cap

30.9M

ML Signal

HOLD

Company Overview

Basic Information
Metric
LIXT
VNCE
Founded
2005
2002
Country
United States
United States
Employees
3
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Clothing/Shoe/Accessory Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
26.5M
30.9M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
LIXT
VNCE
Price
$7.00
$4.39
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$5.17
AVG Volume (30 Days)
140.9K
141.0K
Earning Date
05-08-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
132.45
EPS
N/A
0.49
Revenue
N/A
$300,007,000.00
Revenue This Year
N/A
$5.86
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$9.16
Revenue Growth
N/A
2.23
52 Week Low
$0.64
$1.19
52 Week High
$7.50
$5.90

Technical Indicators

Market Signals
Indicator
LIXT
VNCE
Relative Strength Index (RSI) 67.55 54.55
Support Level $2.92 $3.99
Resistance Level N/A $4.58
Average True Range (ATR) 0.82 0.26
MACD 0.07 -0.02
Stochastic Oscillator 82.94 69.30

Price Performance

Historical Comparison
LIXT
VNCE

About LIXT Lixte Biotechnology Holdings Inc.

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.

About VNCE Vince Holding Corp.

Vince Holding Corp is a fashion brand that is engaged in wholesale and retail delivery of luxury essentials like women's and men's apparel, women's and men's footwear, and handbags. Its offers women's collections of luxurious cashmere sweaters and silk blouses, leather and suede leggings and jackets, dresses, denim, pants, tanks and t-shirts, and a growing assortment of outerwear. It focuses on developing an elevated collection of Vince apparel and accessories to serve the luxurious need of the customer. The company manages its business in three segments namely Vince Wholesale, Vince Direct-to-consumer, and Rebecca Taylor and Parker segment. It operates its e-commerce business through its website. Majority of its revenue generated from Vince Wholesale segment.

Share on Social Networks: